Abstract -Herb extracts commercially used in Korea were screened for PPAR-γ agonist test and α-glucosidase inhibition assay. 
Introduction
The incidence of type II diabetes mellitus (T2DM) has reached epidemic proportions in western and developing countries, with an estimated 194 million people afflicted.
Peripheral insulin resistance is a key feature of T2DM and results from a combination of sedentary lifestyle, unhealthy dietary habits, and genetic predisposition (Skyler, 2004) .
Insulin resistance is also implicated in a number of life threatening disorders collectively referred to as the metabolic syndrome (Hansen, 1999) . T2DM affects many metabolic pathways in different tissues, many of which are potential targets for drug treatment (van de Venter et al., 2008) . Type II diabetes is characterized by hepatic and peripheral (muscle and adipose tissue) insulin resistance. The pancreas compensates by secreting more insulin, but eventually the beta cells will fail to sustain this (Cerasi, 2000) , at which stage the patient requires insulin treatment. During the stage when insulin is still produced, various other classes of drugs, in combination with lifestyle alterations, can be used to manage the disease (Matthaei et al., 2000) . These drugs act through a number of different ways or targets to reduce blood glucose levels.
When screening for an anti-diabetic agent, it is important to include as many of these targets as possible to ensure that possible 'hits' are not excluded (van de Venter et al., 2008) .
PPARs (peroxisome proliferator-activated receptors), the ligand-activated nuclear transcription factors, regulate the gene expression of adipocyte differentiation, lipogenesis, and glucose metabolism, and are involved in type 2 diabetes, dyslipidemia, atherosclerosis, obesity, and other metabolic diseases (Evans et al., 2004; Pakala et al., 2004) . Ligands of PPARs have been used for treating these diseases clinically for decades (Huang et al., 2006) . The thiazolidinedione class of insulin-sensitizing compounds such as rosiglitazone and pioglitazone, which lower hyperglycemia, is PPAR-γ agonists (Stales and Fruchart, 2005) . However, the limitations and the side-effects of these drugs have driven researchers to look for a new type of drug that could be of benefit for the treatment of some of these metabolic disorders.
3T3-L1 fibroblasts transformed to adipocyte when differenti- (Gerhold et al., 2002) , but this mechanism has not been known clearly yet. Known mechanisms is that adipocyte differentiation is starting to be expressed when the transcription factors which operate in genes at fatty tissues specifically is expressed. This transcription factors are peroxisome proliferator-activated receptor γ (PPAR-γ), CCAAT/ enhancing binding protein (C/EBP), adipocyte differentiation and determinator factor 1 and sterol regulatory element binding protein 1c. It is known that substance induced differentiation can convert fibroblast to adipocyte by promoting expressing of these transcription factors. Especially PPAR-γ is able to control the cell growth, start converting of adipocyte, and regulate the adipocyte differentiation. Also C/EBP is expressed in adipocyte and C/EBP helps the PPAR-γ convert preadipocyte to adipocyte (Yamamoto et al., 2002) . Therefore, it is considered that the herb plants, which can differentiate 3T3-L1 fibroblast and increase the lipid accumulation, are able to act as a PPAR-γ agonist.
Current medication options for the treatment of diabetes are relatively limited, have non-negligible side effects, and must often be prescribed in combination (Cheng and Fantus, 2005) . The use of natural health products as complementary or alternative approaches to existing medications is growing in popularity. While these have been the object of very few rigorous scientific studies, it is clear that many plants possess hypoglycemic activity, some having considerable anti-diabetic potential (Marles and Farnsworth, 1995) . The prevalence of use of complementary and alternative medicine (CAM) is high among people with diabetes (Wolsko et al., 2002) and those seeking to prevent chronic diseases that include diabetes (Harnack et al., 2001) .
Active ingredient of medicinal plants that make Korea herb medicine is secondary metabolites with bioactive substances.
Recently insulin like substances from medicinal plants as secondary metabolites, attention has been separated. It has been reported that royal jelly effects on the prevention and treatment of diabetes, because trans-10-hydroxy-2-decanoic acid in royal jelly is insulin like substance (Kameda et al., 1996) .
Also, It has been reported that bakuchiol from Ortholobium pubescens (which is a traditional medicinal plants in Peru) is insulin material (Krenisky et al., 1999) .
In Korea, a traditional medicine, diabetes mellitus could be divided in "So-gal", "So-joong" and "So-sin" broadly and it has been evaluated that So-gal part in Donguibogam is described in detail as these day's diabetes mellitus, and it is amazing. Also, in Asia including Korea, various herbs have been used for treatment of diabetes mellitus. Some studies had found out the anti-diabetic effects of theses herbs, but there are not enough evidences of their anti-diabetic effects.
In this study, we screened the frequent medicinal herbs in Korea traditional medical book, "Donguibogam" by PPAR-γ agonist test and α-glucosidase inhibition assay.
Materials and Methods

Literature search
We had researched the Korea traditional medical book, "Donguibogam", and found out the prescription (Table 1) and frequent herbs (Table 2 ). There were total 54 Korea 
Preparation of plant extracts
Dried herbs were purchased and Oriental medicine doctors used the dried herbs. Herb plants part extracted for each species are shown in Table 2 . Herb plants were extracted with 50% EtOH for 24 hours at room temperature, after they were concentrated under reduced pressure. Samples were freeze-dried and dissolved in dimethylsulfoxide (DMSO). The final sample concentration in DMSO was 10 mg/ml. Samples were kept in freezer at -20°C. (Li et al., 2005) . Also PPAR-γ agonist tests have been used to anti-diabetic effects of some herbal medicines.
PPAR-γ agonist test
But these PPAR-γ agonist tests induced the complete differentiation of 3T3-L1.
In this study, we screened herb medicines for PPAR-γ agonist activity like TZDs (rosiglitazone). The TZD classes of insulin-sensitizing compounds such as rosiglitazone and pioglitazone, which lower hyperglycemia, are PPAR-γ agonists (Staels and Fruchart, 2005) . However, the limitations and the side-effects of these drugs have driven researchers to look for a new type of drug that could be of benefit for the treatment of some of these metabolic disorders. We used MD media (isobutyl-methylxanthine dexamethasone) to differentiate preadipocyte and total 16 herb plants had a PPAR-γ agonist activity (Table 2) (Caspary, 1978) . α -Glucosidase inhibitors block the actions of α-glucosidase enzymes in the small intestine, which is rate-limiting in the conversion of oligosaccharides and disaccharides to monosaccharides, necessary for gastrointestinal absorption. Postprandial glucose peaks may be attenuated by delayed glucose absorption.
The main benefits attributable to α-glucosidase inhibitors are reductions in both postprandial glycemic levels and in the total range of postprandial glucose levels (Chiasson et al., 1994; Lebovitz, 1998) . However, it is well documented that synthetic α-glucosidase inhibitors have undesirable side effects, such as flatulence, diarrhea and abdominal cramping. In addition, some of them may increase the incidence of renal tumors and serious hepatic injury and acute hepatitis (Charpentier et al., 2000; Moller, 2001) .
In this α-glucosidase inhibition assay, 36 herbs had α -glucosidase inhibition (Table 2) In this study, we found out the anti-diabetic effect of herb medicine in Korean traditional medicine by PPAR-γ agonist test and α-glucosidase inhibition assay. Our results of this study provide insight into effects and action mechanism of these herbs, a traditional Korea medicine for diabetes.
